History of CES

Early development

According to the principle of the alpha wave, in 1902, French doctors Leduc and Rouxeau first announced the application of low-intensity electrical stimulation to the brain. In 1949, Soviet scientists applied CES therapy to the treatment of anxiety and sleep disorders. In the initial CES treatment, doctors and researchers often chose to put electrodes on the eyes because they believed that the electric current through the skull was impenetrable. Later, the researchers discovered that placing the electrodes on the earlobe is more convenient and quite effective.


By the 1960s, animal experiments on CES therapy in the United States first began at the University of Tennessee (now Medical University of Wisconsin). Soon the University of Texas Medical School began human clinical trials in San Antonio, and more experiments began.

Recent results

To date, there have been 126 human studies on CES, 29 animal studies, and more than 1,000 research papers on CES treatment, 4 of which have been included in the Library of Congress. The effectiveness of CES has been confirmed in numerous experimental studies and clinical use, and CES does provide relief to patients with anxiety, depression, and insomnia. At present, CES treatment as a global treatment method has more than 27 years of history, and there are more than 300,000 users worldwide. CES treatment equipment in the United States has become a standing treatment instrument for psychiatrists. Many users use it in hospitals with great results. I chose to buy it on my own and treat it at home.


CES Therapy Transcranial Microcurrent Stimulation Therapy

Microcurrent stimulation therapy-induce neurotransmitters

The US FDA clearly regulates that in order to ensure that CES therapy (microcurrent stimulation therapy) is safe and effective, a very low “microampere” safe current must be used (one-millionth of an ampere, which is less than that of a general low-frequency therapeutic apparatus. 1/100), allowing users to secrete various neurotransmitters on their own to directly induce the brain, hypothalamus, and prefrontal cortex that are responsible for mental and emotional activities to produce “endorphins”, “acetylcholine”, “Serotonin” and other neurotransmitters that the human body can synthesize by itself to achieve the effects of regulating emotional cognition, improving abnormal brain waves, strengthening alpha waves, eliminating tension, relaxing… and so on, so it can effectively treat insomnia and relieve stress. The effect can be expected.


Compared with drug therapy, CES therapy has no side effects and has a stable effect. It has been widely used in Europe and the United States as a safe and effective treatment to replace or assist drug therapy.


4 main features

Mechanism of action

CES therapy can stimulate the brain to secrete endorphins (endorphins) that regulate emotions, which can make people’s minds and bodies in a relaxed and happy state, strengthen the immune system, and help sleep.

CES therapy can stimulate the brain to secrete acetylcholine (ACh), which enhances cognition, help clear consciousness, increase the speed of neuronal information transmission, enhance brain memory, and improve brain function in an all-around way.

Significantly enhances the power of brain wave alpha (brain relaxed state) and reduces the power of brain wave delta (brain sleepiness and fatigue state), which can improve abnormal brain waves and return the brain from an abnormal state to a normal state.

Can quickly reduce the secretion of stress hormones, improve physiological signals, such as heart rate, blood pressure, muscle tension, skin electricity, skin temperature, effectively control tension, anxiety, and depression, and regulate emotional state


CES Therapy A Safe Choice

FDA approved

The equipment implementing CES therapy has been revised by the US FDA as a Class 2 medical device in December 2019, and its safety management specifications are equivalent to that of a sphygmomanometer; the current FDA-approved indications for the device are insomnia, depression, anxiety, and pain.

No drug side effects

As a non-medicinal medical treatment, CES therapy has had almost no side effects in the past 30 years, only about 8,800 people have shown very minor side effects. Among them, there is only a 0.10% chance of having a headache and a 0.07% chance of having a skin allergy or inflammation.

Multi-country clinical use

CES therapy has more than 30 years of clinical use records in European and American countries. It has obtained two US patents, FDA, and various safety regulations. At the same time, it is currently an auxiliary treatment method used by sleep specialist clinics and psychiatrists, and many medical practitioners.

No field restrictions

CES therapy equipment has undergone decades of continuous progress in research and development, and related research and development equipment manufacturers have been able to develop devices that are about the size of a smartphone. Therefore, whether it is used at home or on the go, the treatment can be easily completed.

Scroll to Top